Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Ventyx Biosciences, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-05-22Dec-31-21Dec-05-21Dec-31-20Dec-31-19
Revenues0.087.70.058.50.03.6
            Revenue growth 50.0%  -100.0% 
Cost of goods sold0.0113.10.067.10.07.1
Gross profit0.0-25.40.0-8.70.0-3.6
            Gross margin -28.9% -14.8% -100.0%
Selling, general and administrative113.1 67.1   
Research and development    6.4 
General and administrative 25.4 8.70.70.6
EBIT-103.7-113.1-78.7-67.1-7.1-4.2
            EBIT margin -128.9% -114.8% -117.7%
Pre-tax income-108.4-108.4-83.7-83.7-28.2-4.3
Income taxes0.00.00.00.00.00.0
            Tax rate0.0%0.0%0.0%0.0%0.0%0.0%
Net income-108.4-0.1-83.7-0.1-28.20.0
            Net margin -0.1% -0.1% -0.1%
 
Diluted EPS($2.07)($2.07)($6.53)($6.65)($14.17)($2.60)
Shares outstanding (diluted)52.50.112.80.02.00.0
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy